These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8295009)

  • 41. Transferability of a two-strip method for the quality control of technetium-99m mercaptoacetyltriglycine ([
    Tessaire T; De Neef L; Cailly T; Peyronnet D; Vigne J
    Eur J Hosp Pharm; 2023 May; 30(3):167-171. PubMed ID: 34285112
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 99Tcm-MAG3: problems with radiochemical purity testing.
    Murray T; McKellar K; Owens J; Watson WS; Hilditch TE; Elliott AT
    Nucl Med Commun; 2000 Jan; 21(1):71-5. PubMed ID: 10717905
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of solvent flow rate in mini-column testing of 99mTc-mertiatide.
    Ponto JA
    J Nucl Med Technol; 2005 Dec; 33(4):232-3. PubMed ID: 16322124
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A rapid chromatographic method for quality control of technetium-99m-bicisate.
    Amin KC; Saha GB; Go RT
    J Nucl Med Technol; 1997 Mar; 25(1):49-51. PubMed ID: 9239604
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Preparation and quality control of 99mTc labeled MDR1 oligonucleotide DNAs].
    Fan C; Hnatowich DJ
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Jun; 25(3):712-5. PubMed ID: 18693462
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 3'-99mTc-labeling and biodistribution of a CAPL antisense oligodeoxynucleotide.
    Hjelstuen OK; Tønnesen HH; Bremer PO; Verbruggen AM
    Nucl Med Biol; 1998 Oct; 25(7):651-7. PubMed ID: 9804046
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preparation, radiochemical purity control and stability of 99mTc-mertiatide (Mag-3).
    van Hemert FJ; van Lenthe H; Schimmel KJ; van Eck-Smit BL
    Ann Nucl Med; 2005 Jun; 19(4):345-9. PubMed ID: 16097648
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bifunctional NHS-BAT ester for antibody conjugation and stable technetium-99m labeling: conjugation chemistry, immunoreactivity and kit formulation.
    Eisenhut M; Lehmann WD; Becker W; Behr T; Elser H; Strittmatter W; Steinsträsser A; Baum RP; Valerius T; Repp R; Deo Y
    J Nucl Med; 1996 Feb; 37(2):362-70. PubMed ID: 8667077
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preparation of the renal function and imaging agent 99mTc-MAG3 starting from S-unprotected mercaptoacetyltriglycine.
    Noll B; Johannsen B; May K; Spies H
    Int J Rad Appl Instrum A; 1992 Jul; 43(7):899-901. PubMed ID: 1321100
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparison of SepPak and high-performance liquid chromatography as techniques for measuring the radiochemical purity of 99mTc-MAG3.
    Millar AM; Hesslewood SR
    Nucl Med Commun; 2004 Oct; 25(10):1049-51. PubMed ID: 15381873
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Current topics in radiopharmaceuticals in Japan. (IV). Quality control of "Kit" made radiopharmaceuticals--radiochemical purity of 99mTc radiopharmaceuticals].
    Yokoyama A
    Radioisotopes; 1984 Mar; 33(3):170-9. PubMed ID: 6382453
    [No Abstract]   [Full Text] [Related]  

  • 52. A study of the concept of non-radioactive unit-dosed reagent kits [cold unit doses (CUDs)] as an efficient and cost-saving method for 99mTc radiopharmaceutical preparation.
    Lerthirunwong C; Cheng KT; Hladik WB
    Int J Rad Appl Instrum B; 1992 Oct; 19(7):727-35. PubMed ID: 1399692
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The use of redox polymers in labelling procedures of proteins and peptides with 99mTc. II. Technique of preparation of kits for protein labelling by 99mTc and its effect on the stability and radiochemical purity.
    Komárek P; Kleisner I; Komárková I; Konopková M
    Nucl Med Rev Cent East Eur; 2000; 3(1):69-72. PubMed ID: 14600985
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human polyclonal immunoglobulin labelled with technetium-99m via NHS-MAG3: a comparison of radiochemical behavior and biological efficacy with other labelling methods.
    Gano L; Patrício L; Marques E; Cantinho G; Pena H; Martins T; Hnatowich DJ
    Nucl Med Biol; 1998 May; 25(4):395-403. PubMed ID: 9639302
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Peri-aortofemoral prosthesis urinoma: diagnosis by Tc-99m MAG3 SPECT/CT and differentiation from simultaneous hepatobiliary excretion.
    Ngai S; Stuckey SL
    Clin Nucl Med; 2008 May; 33(5):337-9. PubMed ID: 18431149
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of radiolytic-produced hydrogen peroxide on the stability of commercial kit (99m) technetium-exametazime preparation.
    Martinez T; Miñana E; Martín-Falquina TC; Fuente T
    J Labelled Comp Radiopharm; 2014 Jan; 57(1):49-52. PubMed ID: 24448745
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characteristics and biological behaviour of 99mTc-labelled hydroxyacetyltriglycine, a potential alternative to 99mTc-MAG3.
    Vanbilloen HP; Dezutter NA; Cleynhens BJ; Verbruggen AM
    Eur J Nucl Med; 1997 Nov; 24(11):1374-9. PubMed ID: 9371870
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Electrolytic complexing of glucoheptonate and technetium-99m.
    Chi SL; Hoag SG; Yanchick VA
    J Nucl Med; 1978 May; 19(5):520-4. PubMed ID: 641575
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect on radiochemical purity of modifications to the method of preparation and dilution of 99mTc-sestamibi.
    Cooper M; Dustan K; Rotureau L
    Nucl Med Commun; 2006 May; 27(5):455-60. PubMed ID: 16609357
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Simplified method for determining the radiochemical purity of 99mTc-MAG3.
    Seetharaman S; Ballinger JR; Sosabowski MH
    J Nucl Med Technol; 2006 Sep; 34(3):179-83. PubMed ID: 16951288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.